Searched for
CINV
Glenmark introduces medication to prevent chemotherapy-induced nauseaThe company has introduced IV injection formulation Akynzeo IV in a fixed dose combination of fosnetupitant (235 mg) and palonosetron (0.25...- Glenmark launches Akynzeo in India under licensing pact with HelsinnGlenmark Pharmaceuticals today launched Akynzeo, a drug used for prevention chemotherapy-induced nausea and vomiting, in India and Nepal.
- Stocks in focus: HUL & TCS at fresh 52-week highs; IDBI Bank up 10%According to a report by ET, MCX and NSE are in talks to team up for bigger exchange play.
- Load More